Christoph Petry

Christoph Petry has a diverse work experience spanning multiple industries and roles. Christoph has extensive experience in the healthcare and life sciences sectors. From 1993 to 2006, Petry worked at Bayer HealthCare, where they held various positions, including Department Head of Corporate Research and Head of Diagnostics Research Germany. Christoph then joined Siemens Healthineers in 2007 as the Head of Molecular Research Germany. In 2010, Petry founded Sividon Diagnostics GmbH, where they served as Founder, Managing Director, and CEO until 2016. From 2017 to 2021, they worked as an Independent Consultant at Petry Life Sciences Consulting GmbH, providing specialized consulting services. Additionally, Petry held the role of Managing Director at m2p-labs GmbH, where they successfully restructured the company and managed its integration into Beckman Coulter. Christoph also served as an Integration Management professional at Beckman Coulter from 2021 to 2022. In November 2022, Christoph Petry will be taking on the role of Managing Director at faCellitate.

Christoph Petry completed their Abitur at Gymnasium Philippinum Weilburg from 1975 to 1984. Christoph then pursued Chemistry at Heidelberg University from 1985 to 1987, earning a Vordiplom. Subsequently, they attended FAU Erlangen-Nürnberg from 1987 to 1990 and obtained a Diplom in Chemistry. Finally, Petry attended Max Planck Institut für Medizinische Forschung Heidelberg from 1990 to 1993, where they completed their Ph.D. in Organic Chemistry.